| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1093/HUMUPD/DMI037 |
| P698 | PubMed publication ID | 16172112 |
| P50 | author | Annalisa Abbiati | Q122852875 |
| Paola Viganò | Q38641751 | ||
| Edgardo Somigliana | Q56454849 | ||
| Paolo Vercellini | Q57008851 | ||
| P2093 | author name string | Ilda Chiodo | |
| P2860 | cites work | P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 |
| Early events in ovarian oncogenesis | Q24805567 | ||
| Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers | Q28145813 | ||
| Comparative immunohistochemical studies of endometriosis lesions and endometriotic cysts | Q30861030 | ||
| Resolution of clonal origins for endometriotic lesions using laser capture microdissection and the human androgen receptor (HUMARA) assay | Q31134258 | ||
| Allelic loss studies do not provide evidence for the "endometriosis-as-tumor" theory | Q31160002 | ||
| GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer | Q31835324 | ||
| Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype | Q31835337 | ||
| Griseofulvin potentiates antitumorigenesis effects of nocodazole through induction of apoptosis and G2/M cell cycle arrest in human colorectal cancer cells | Q31911825 | ||
| Analysis of the clonality of ectopic glands in peritoneal endometriosis using laser microdissection | Q33194816 | ||
| Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence | Q33597528 | ||
| Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy | Q33826374 | ||
| The multiple roles of PTEN in tumor suppression | Q33849727 | ||
| Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas | Q33951414 | ||
| Recommendations for the design of epidemiologic studies of endometriosis | Q34072511 | ||
| Evidence that endometriosis behaves in a malignant manner. | Q34090884 | ||
| Common genetic changes between endometriosis and ovarian cancer | Q34090909 | ||
| Molecular genetic defects in endometriosis. | Q34090914 | ||
| Endometriosis: candidate genes. | Q34158341 | ||
| Monoclonality of endocrine tumours: What does it mean? | Q34336936 | ||
| What makes a good case-control study? Design issues for complex traits such as endometriosis. | Q34664382 | ||
| TP53 and ovarian cancer | Q35078757 | ||
| Genetics of endometriosis. | Q35108915 | ||
| Endometriosis and ovarian cancer: thoughts on shared pathophysiology | Q35177953 | ||
| Endometriosis: the ultimate hormonal disease | Q35199226 | ||
| Ovarian cancer and polymorphisms in the androgen and progesterone receptor genes: a HuGE review | Q35652575 | ||
| Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. | Q35745475 | ||
| Evidence of the monoclonal composition of human endometrial epithelial glands and mosaic pattern of clonal distribution in luminal epithelium | Q35791651 | ||
| A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma. | Q36080535 | ||
| Bcl-2 and the regulation of programmed cell death | Q36233600 | ||
| Expression of the cyclin-dependent kinase inhibitor p27Kip1 in eutopic endometrium and peritoneal endometriosis | Q38301199 | ||
| Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis | Q38456439 | ||
| Increased heterogeneity of chromosome 17 aneuploidy in endometriosis | Q38468922 | ||
| Polymorphisms of the genes encoding the GSTM1, GSTT1 and GSTP1 in Korean women: no association with endometriosis | Q38515951 | ||
| Screening for clonal genetic alterations | Q40423678 | ||
| Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study | Q40630309 | ||
| Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation | Q41100590 | ||
| bcl-2 protein in non-small-cell lung carcinoma | Q42508274 | ||
| Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives | Q43773289 | ||
| Linkage and association studies of the relationship between endometriosis and genes encoding the detoxification enzymes GSTM1, GSTT1 and CYP1A1. | Q43776016 | ||
| Low-penetrance genes are associated with increased susceptibility to endometriosis | Q43813775 | ||
| PROGINS receptor gene polymorphism is associated with endometriosis | Q43872539 | ||
| PROGINS Alu insertion and human genomic diversity | Q43948396 | ||
| Human progesterone receptor gene polymorphism PROGINS and risk for breast cancer in Austrian women | Q44011321 | ||
| Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium | Q44156656 | ||
| Microsatellite DNA assays reveal an allelic imbalance in p16(Ink4), GALT, p53, and APOA2 loci in patients with endometriosis. | Q44646174 | ||
| Reduction of apoptosis and proliferation in endometriosis | Q44966171 | ||
| Genetics of endometriosis: a role for the progesterone receptor gene polymorphism PROGINS? | Q44992368 | ||
| Glutathione S-transferase M1*null genotype but not myeloperoxidase promoter G-463A polymorphism is associated with higher susceptibility to endometriosis | Q45010362 | ||
| A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk. | Q45173699 | ||
| Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer | Q45201949 | ||
| GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and their relationship with advanced stages of endometriosis in South Indian women | Q46463347 | ||
| Apoptosis and differential expression of apoptosis-related proteins in endometriotic glandular and stromal cells | Q47284619 | ||
| Increased prevalence of p53 overexpression from typical endometriosis to atypical endometriosis and ovarian cancer associated with endometriosis | Q47906975 | ||
| p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer | Q48023151 | ||
| Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53. | Q50866250 | ||
| bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas. | Q53368918 | ||
| Analysis of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in endometriosis. | Q53384331 | ||
| Demonstration of focal p53 expression without genetic alterations in endometriotic lesions. | Q53397349 | ||
| Cytogenetic studies in endometriosis tissue. | Q54249696 | ||
| Derivation of mouse intestinal crypts from single progenitor cells | Q59060822 | ||
| P433 | issue | 1 | |
| P921 | main subject | endometriosis | Q205764 |
| P304 | page(s) | 77-89 | |
| P577 | publication date | 2005-09-19 | |
| P1433 | published in | Human Reproduction Update | Q15724523 |
| P1476 | title | Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis | |
| P478 | volume | 12 |
| Q35100056 | A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation |
| Q64124105 | A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254) |
| Q30370823 | ARID1A Is Essential for Endometrial Function during Early Pregnancy |
| Q24610484 | ARID1A mutations in endometriosis-associated ovarian carcinomas |
| Q47107325 | Aberrant chromatin remodeling in gynecological cancer |
| Q44543909 | Aberrant histone acetylation and methylation levels in woman with endometriosis |
| Q92764838 | Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway |
| Q84866697 | Cadherin expression in gastrointestinal tract endometriosis: possible role in deep tissue invasion and development of malignancy |
| Q35020913 | Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling |
| Q34400984 | Common chromosomal imbalances and stemness-related protein expression markers in endometriotic lesions from different anatomical sites: the potential role of stem cells. |
| Q58788504 | Comparative study of endometrioid borderline ovarian tumor with and without endometriosis |
| Q41343787 | Deep Invasive Endometriosis Lesions of the Rectosigmoid May Be Related to Alterations in Cell Kinetics |
| Q42861080 | Deregulation of LOXL1 and HTRA1 gene expression in endometriosis |
| Q46959757 | Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis |
| Q58860618 | Endometriosis and Cancer: Epidemiology |
| Q38284360 | Endometriosis and cancer. |
| Q34657664 | Endometriosis and ovarian cancer. |
| Q35615166 | Endometriosis gene expression heterogeneity and biosignature: a phylogenetic analysis |
| Q26768656 | Endometriosis-associated Malignancy |
| Q37465188 | Endometriosis: current therapies and new pharmacological developments. |
| Q38173642 | Endometriosis: pathogenesis and treatment. |
| Q35116928 | Epithelial ovarian carcinoma types and the coexistence of ovarian tumor conditions. |
| Q37624069 | Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy. |
| Q92618041 | Hypoxia, cytokines and stromal recruitment: parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis |
| Q36099250 | Identification of multiple pathways involved in the malignant transformation of endometriosis (Review) |
| Q33868280 | Increased expression of ID2, PRELP and SMOC2 genes in patients with endometriosis. |
| Q45230026 | Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis |
| Q36751649 | MUC1 in endometriosis and ovarian cancer |
| Q34517694 | Major clinical research advances in gynecologic cancer in 2010 |
| Q38441719 | Malignant Transformation of Pelvic Endometriosis: Case Series and Review of the Literature |
| Q36817471 | Microscopic lesions of fallopian tubes in endometrioid carcinoma of the endometrium: How effective are the macroscopic tubal sampling techniques? |
| Q53292726 | Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis. |
| Q37988818 | Principles of phenomics in endometriosis |
| Q37221118 | Prognostic implication of endometriosis in clear cell carcinoma of the ovary |
| Q36089391 | Shared genetics underlying epidemiological association between endometriosis and ovarian cancer |
| Q51763725 | Status of HER1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma. |
| Q45792166 | The 'incessant menstruation' hypothesis: a mechanistic ovarian cancer model with implications for prevention |
| Q26785614 | The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life |
| Q85187684 | The Origin of Ovarian Cancer — Is It Getting Clearer? |
| Q37950143 | The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations |
| Q34377973 | The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. |
| Q36742613 | The endometriotic tissue lining the internal surface of endometrioma: hormonal, genetic, epigenetic status, and gene expression profile. |
| Q36121341 | The role of components of the chromatin modification machinery in carcinogenesis of clear cell carcinoma of the ovary (Review) |
| Q47741754 | Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience |
| Q37718273 | Up-regulation of ribosome biogenesis by MIR196A2 genetic variation promotes endometriosis development and progression |
| Q58860707 | Vitamin D reserve is higher in women with endometriosis |
Search more.